Skip to main content

Table 1 Genomic analysis (FoundationOne CDx) of recurrent tumors in the colon (China Medical University Hospital)

From: Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report

Finding

Result

Biomarkers

 Microsatellite status (MS)

Stable

 Tumor mutational burden (TMB)

Low

Genomic data

 ARID1A

M1154fs*7, Y788*

 ERBB2

Amplification

 APC

G2400*

 GABRA6

K110T

 TERT promoter

124C > 7

 TP53

R280K

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us